Monday, October 24, 2011

Similar remission results shown between once-daily 4g dose and twice-daily 2g doses of mesalazine (PENTASA®) in active ulcerative colitis

|More|
Thursday, October 20, 2011

Ferring Pharmaceuticals acquires Cytokine PharmaSciences Inc.

|More|
Friday, September 02, 2011

New research reveals night-time toilet trips are not a trivial problem

|More|
Friday, September 02, 2011

The untold impact of childhood bedwetting in later life

|More|
Wednesday, August 31, 2011

New data demonstrating long-term benefits of FIRMAGON® (degarelix) for advanced hormone-dependant prostate cancer published in The Journal of Urology

|More|
Wednesday, July 06, 2011

MEGASET Study demonstrated effectiveness and tolerability of MENOPUR® after ICSI in GnRH antagonist cycles

|More|
Monday, March 21, 2011

Ongoing extension study results provide further evidence for first-line use of FIRMAGON® (degarelix) in advanced prostate cancer

|More|
Monday, January 17, 2011

SMC Announces Acceptance of Degarelix (FIRMAGON®▼)for use within NHS Scotland

|More|
 

By using the service, you agree to the following:

Your email address and the recipient's email address will be used for transmission purposes only - to inform the addressee about the sender, or for sending a message in the event of a transmission error. Both email addresses will be deleted from our system after a short period.